Brain activation measured with functional near-infrared spectroscopy during pelvic floor muscle contraction: a pilot study.

Withdrawn

• Conditions: stress urinary incontinence.; Urine leakage; 10004994

• Registration Number: NL-OMON49974
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

- Referred for physical therapy to treat mixed (predominant SUI) or SUI
- Right-handed
- Female, between the age of 18 up to and including 60 years old
- Signed informed consent

Exclusion Criteria

- Using any medication for urinary complaints.
- Using any medication which may influence the function of the lower urinary
tract (i.e. neuroleptics, anti-depressants, morphine-like medication).
- Having had PFMT in the past six months.
- Any known neurological disorder.
- Any known psychiatric disorder.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Change in the oxygenated haemoglobin concentration in the motor and sensory<br /><br>cortex, change in the deoxygenated haemoglobin concentration in the motor and<br /><br>sensory cortex change in pelvic floor muscle force, change in pelvic floor<br /><br>muscle endurance, change in pelvic floor coordination, change in symptom<br /><br>severity, change in health related quality of life, correlation between<br /><br>cortical activation measured by fNIRS (oxygenated haemoglobin) and pelvic floor<br /><br>activity measured by EMG. </p><br>